101 related articles for article (PubMed ID: 7540207)
1. Novel inhibitors of potassium ion channels on human T lymphocytes.
Michne WF; Guiles JW; Treasurywala AM; Castonguay LA; Weigelt CA; Oconnor B; Volberg WA; Grant AM; Chadwick CC; Krafte DS
J Med Chem; 1995 May; 38(11):1877-83. PubMed ID: 7540207
[TBL] [Abstract][Full Text] [Related]
2. WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Hill RJ; Grant AM; Volberg W; Rapp L; Faltynek C; Miller D; Pagani K; Baizman E; Wang S; Guiles JW
Mol Pharmacol; 1995 Jul; 48(1):98-104. PubMed ID: 7542739
[TBL] [Abstract][Full Text] [Related]
3. Characterization of high affinity binding sites for charybdotoxin in human T lymphocytes. Evidence for association with the voltage-gated K+ channel.
Deutsch C; Price M; Lee S; King VF; Garcia ML
J Biol Chem; 1991 Feb; 266(6):3668-74. PubMed ID: 1704892
[TBL] [Abstract][Full Text] [Related]
4. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
5. Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin.
Leonard RJ; Garcia ML; Slaughter RS; Reuben JP
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10094-8. PubMed ID: 1279670
[TBL] [Abstract][Full Text] [Related]
6. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels.
Knaus HG; McManus OB; Lee SH; Schmalhofer WA; Garcia-Calvo M; Helms LM; Sanchez M; Giangiacomo K; Reuben JP; Smith AB
Biochemistry; 1994 May; 33(19):5819-28. PubMed ID: 7514038
[TBL] [Abstract][Full Text] [Related]
7. Charybdotoxin blocks voltage-gated K+ channels in human and murine T lymphocytes.
Sands SB; Lewis RS; Cahalan MD
J Gen Physiol; 1989 Jun; 93(6):1061-74. PubMed ID: 2475579
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic localization of [125I]charybdotoxin binding sites in rat brain.
Gehlert DR; Gackenheimer SL; Robertson DW
Neurosci Lett; 1992 Jun; 140(1):25-9. PubMed ID: 1383889
[TBL] [Abstract][Full Text] [Related]
9. Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels.
Giangiacomo KM; Sugg EE; Garcia-Calvo M; Leonard RJ; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 1993 Mar; 32(9):2363-70. PubMed ID: 7680230
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the distribution of binding sites for the potassium channel ligands [125I]apamin, [125I]charybdotoxin and [125I]iodoglyburide in the rat brain.
Gehlert DR; Gackenheimer SL
Neuroscience; 1993 Jan; 52(1):191-205. PubMed ID: 7679479
[TBL] [Abstract][Full Text] [Related]
11. Diverse K+ channels in primary human T lymphocytes.
Lee SC; Levy DI; Deutsch C
J Gen Physiol; 1992 May; 99(5):771-93. PubMed ID: 1376766
[TBL] [Abstract][Full Text] [Related]
12. UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.
Hanson DC; Nguyen A; Mather RJ; Rauer H; Koch K; Burgess LE; Rizzi JP; Donovan CB; Bruns MJ; Canniff PC; Cunningham AC; Verdries KA; Mena E; Kath JC; Gutman GA; Cahalan MD; Grissmer S; Chandy KG
Br J Pharmacol; 1999 Apr; 126(8):1707-16. PubMed ID: 10372812
[TBL] [Abstract][Full Text] [Related]
13. A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels.
Verheugen JA; Korn H
J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):317-31. PubMed ID: 9306275
[TBL] [Abstract][Full Text] [Related]
14. Multiple types of voltage-dependent Ca2+-activated K+ channels of large conductance in rat brain synaptosomal membranes.
Farley J; Rudy B
Biophys J; 1988 Jun; 53(6):919-34. PubMed ID: 2456105
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties.
Schmalhofer WA; Bao J; McManus OB; Green B; Matyskiela M; Wunderler D; Bugianesi RM; Felix JP; Hanner M; Linde-Arias AR; Ponte CG; Velasco L; Koo G; Staruch MJ; Miao S; Parsons WH; Rupprecht K; Slaughter RS; Kaczorowski GJ; Garcia ML
Biochemistry; 2002 Jun; 41(24):7781-94. PubMed ID: 12056910
[TBL] [Abstract][Full Text] [Related]
16. Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology.
Grissmer S; Nguyen AN; Cahalan MD
J Gen Physiol; 1993 Oct; 102(4):601-30. PubMed ID: 7505804
[TBL] [Abstract][Full Text] [Related]
17. Margatoxin binds to a homomultimer of K(V)1.3 channels in Jurkat cells. Comparison with K(V)1.3 expressed in CHO cells.
Helms LM; Felix JP; Bugianesi RM; Garcia ML; Stevens S; Leonard RJ; Knaus HG; Koch R; Wanner SG; Kaczorowski GJ; Slaughter RS
Biochemistry; 1997 Mar; 36(12):3737-44. PubMed ID: 9132027
[TBL] [Abstract][Full Text] [Related]
18. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
Gao YD; Garcia ML
Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
[TBL] [Abstract][Full Text] [Related]
19. Effects of charybdotoxin on K+ channel (KV1.2) deactivation and inactivation kinetics.
Sprunger LK; Stewig NJ; O'Grady SM
Eur J Pharmacol; 1996 Oct; 314(3):357-64. PubMed ID: 8957259
[TBL] [Abstract][Full Text] [Related]
20. Interactions between dendrotoxin, a blocker of voltage-dependent potassium channels, and charybdotoxin, a blocker of calcium-activated potassium channels, at binding sites on neuronal membranes.
Harvey AL; Marshall DL; De-Allie FA; Strong PN
Biochem Biophys Res Commun; 1989 Aug; 163(1):394-7. PubMed ID: 2476127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
